论文信息 - Farletuzumab for NSCLC: exploiting a well-known metabolic pathway for a new therapeutic strategy - 字舞流文

Farletuzumab for NSCLC: exploiting a well-known metabolic pathway for a new therapeutic strategy

A. Russo | V. Bazan | G. Bronte | C. Rolfo | G. Cicero | E. Fiorentino | A. Galvano | Francesca Lo Vullo | G. Pernice